LeMaitre Vascular Raises FY2025 GAAP EPS Guidance from $2.23-$2.37 to $2.48-$2.53 vs $2.27 Est; Lowers FY2025 Sales Guidance from $248.000M-$254.000M to $247.000M-$249.000M vs $250.617M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.23-$2.37 to $2.48-$2.53 vs $2.27 analyst estimate. Lowers FY2025 sales outlook from $248.000 million-$254.000 million to $247.000 million-$249.000
LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.23-$2.37 to $2.48-$2.53 vs $2.27 analyst estimate. Lowers FY2025 sales outlook from $248.000 million-$254.000 million to $247.000 million-$249.000 million vs $250.617 million estimate.